VectivBio is a biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases. Founded by Luca Santarelli in 2019, VectivBio is backed by investors that include OrbiMed, Bpifrance, Novo Holdings, Versant Ventures, and Surveyor Capital and is headquartered in Basel.